AISight Clinical Trials

AISight Clinical Trials is a secure, cloud-based SaaS platform designed to support AI-powered digital pathology reads within clinical trial workflows. Built for both prospective and retrospective studies, the platform enables life sciences organizations and research teams to deploy AI algorithms and facilitate remote central pathology analysis at scale.

The platform is highly configurable and scalable, accommodating a wide range of use cases including eligibility and stratification assessments, response monitoring, quality control, and exploratory analysis. Its flexibility makes it suitable for even the most complex pathology read strategies in clinical research settings.

Core Platform Capabilities

• Easy, automated bulk ingestion of whole slide images and associated metadata on a user-defined schedule
• Cloud-based, remote access enabling rapid study startup and faster result turnaround
• Highly configurable and customizable workflows to support complex pathology read strategies
• Support for both prospective and retrospective clinical trial designs
• Add-on exploratory analysis features including PathExplore, NASH Explore, and IBD Explore

Features and Functionality

• Quality control analytics supported by dynamic, auto-generated data visualizations
• Comparison of manual versus AI scoring concordance with automatically generated kappa values
• Easy-to-use dashboards supporting accession tracking throughout the digital life cycle
• Key results available at both the accession and cumulative levels, segmentable by site or laboratory
• Direct download of results through the platform interface

Quality and Compliance Standards

• GCP/GCLP compliant
• 21 CFR Part 11 compliant
• ISO 27001 certified

AISight Clinical Trials is intended for research use only and is not for use in diagnostic procedures. The platform is also available to anatomic pathology laboratories as a state-of-the-art image management system under the AISight for AP Laboratories offering.